C57BL/6J-Zfp469em1Chms/H

Status

Available to order

EMMA IDEM:15253
Citation informationRRID:IMSR_EM:15253 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC57BL/6J-Zfp469em1Chms/H
Alternative nameZfp469 BCS
Strain typeEndonuclease-mediated
Allele/Transgene symbolZfp469em1Chms
Gene/Transgene symbolZfp469

Information from provider

ProviderVeronique Vitart
Provider affiliationMRC HGU, University of Edinburgh
Genetic informationZfp469em1Chms: this allele was generated by injecting Cas9 mRNA and guide RNAs resulting in an in-frame V5 tag and premature stop codon inserted into Zfp469 at p.Gly634, the conserved residue equivalent to the human mutation p.Gly677*.
Phenotypic informationHomozygous:
Homozygous carriers of the Brittle Cornea Syndrome 1 (BCS1) allele have significantly thinner corneas as a result of stromal thinning. The structure of the cornea is altered, with thinner collagen fibrils and reduced biomechanical strength. Unlike the human condition of Brittle Cornea Syndrome, no instances of corneal rupture have been observed in these mice. Corneal thinning occurs during development and is not progressive (monitored up to 6 months of age). Histological investigation revealed reduced collagen deposition in the skin suggesting a more widespread connective tissue phenotype without obvious adverse effect or impact on welfare. The line has been aged to 9 months with no adverse affects observed. The mice are fertile.

Heterozygous:
No significant phenotypic difference with wild-type strain observed.
Breeding historyMore than 10 backcrosses (C57BL/6J).
References
  • A mouse model of brittle cornea syndrome caused by mutation in Zfp469.;Stanton Chloe M, Findlay Amy S, Drake Camilla, Mustafa Mohammad Z, Gautier Philippe, McKie Lisa, Jackson Ian J, Vitart Veronique, ;2021;Disease models & mechanisms;14;; 34368841
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom

Disease and phenotype information

IMPC phenotypes (gene matching)
  • abnormal auditory brainstem response / IMPC
  • cataract / IMPC
  • enlarged kidney / IMPC
  • decreased body length / IMPC
  • increased circulating alkaline phosphatase level / IMPC
  • abnormal seminal vesicle morphology / IMPC
  • abnormal kidney morphology / IMPC
  • decreased grip strength / IMPC
  • increased lymphocyte cell number / IMPC
  • increased leukocyte cell number / IMPC
  • abnormal vitreous body morphology / IMPC

Literature references

  • A mouse model of brittle cornea syndrome caused by mutation in Zfp469.;Stanton Chloe M, Findlay Amy S, Drake Camilla, Mustafa Mohammad Z, Gautier Philippe, McKie Lisa, Jackson Ian J, Vitart Veronique, ;2021;Disease models & mechanisms;14;; 34368841

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*
  • Tissue - Types of tissue, service fee and delivery time available upon request

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable), as well as a CRISPR surcharge.

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).